Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,666   1.18  Index Moved Down -0.07%
JNJ PFE NVS SNY Heavy Metals Advertising Government Railroads 
United States  USA  |  Investing Themes


Processing
Collecting data for TEVA and KUB ...

Asset Comparison and Correlation

    
Investment horizon: 
  30 Days    Login   to change
 
 Teva Pharmaceutical Industries  vs   Kubota Corp.
 Compare Fundamentals  
Daily Returns (%)
KUB   TEVA   
 
Given investment horizon of 30 days, Teva is expected to generate 2.62 times less return on investment than Kubota. But when comparing it to its historical volatility, Teva Pharmaceutical Industries Limited is 4.11 times less risky than Kubota. It trades about 0.33 of its potential returns per unit of risk. Kubota Corporation is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  7,346  in Kubota Corporation on April 21, 2013 and sell it today you would earn a total of  1,090  from holding Kubota Corporation or generate 14.84% return on investment over 30 days.

Diversification

Modest diversification
Overlapping area represents amount of risk that can be diversified away by holding Teva Pharmaceutical Industries and Kubota Corp. in the same portfolio assuming nothing else is changed

Correlation Coefficient

0.22
Parameters
Time Period1 Month [change]
DirectionPositive KUB Moved Up vs TEVA
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns
Follow Correlation between TEVA and KUB with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Correlation between TEVA and KUB to your reader
 
Share Correlation between TEVA and KUB 
Find Opportunities
 
Predicted Return Density
 
Returns   
KUB   TEVA   

Teva Pharmaceutical Industries Limited

 
    
Teva
Performance
17
Out Of
100
Over 30
Days
83% of all equities and portfolios perform better than Teva Pharmaceutical Industries Limited. Compared with the overall equity markets, risk-adjusted returns on investments in Teva Pharmaceutical Industries Limited are ranked lower than 17 (%) of all global equities and portfolios over the last 30 days.
    

Match ups for Teva

Novo Nordisk A-S vs. Teva Pharmaceutical Industries Limited
Allergan Inc vs. Teva Pharmaceutical Industries Limited
Forest Laboratories Inc vs. Teva Pharmaceutical Industries Limited
Dr Reddys Laboratories Ltd vs. Teva Pharmaceutical Industries Limited
Pharmacyclics Inc vs. Teva Pharmaceutical Industries Limited
Warner Chilcott plc vs. Teva Pharmaceutical Industries Limited
Endo Health Solutions Inc vs. Teva Pharmaceutical Industries Limited
United Therapeutics Corporation vs. Teva Pharmaceutical Industries Limited
Cubist Pharmaceuticals Inc vs. Teva Pharmaceutical Industries Limited
  

Kubota Corporation

 
    
Kubota
Performance
11
Out Of
100
Over 30
Days
89% of all equities and portfolios perform better than Kubota Corporation. Compared with the overall equity markets, risk-adjusted returns on investments in Kubota Corporation are ranked lower than 11 (%) of all global equities and portfolios over the last 30 days.
    

Match ups for Kubota

General Electric Company vs. Kubota Corporation
Siemens Aktiengesellschaft vs. Kubota Corporation
United Technologies Corp vs. Kubota Corporation
Honeywell International Inc vs. Kubota Corporation
Danaher Corp vs. Kubota Corporation
Illinois Tool Works Inc vs. Kubota Corporation
Koninklijke Philips Electronics NV vs. Kubota Corporation
Cummins Inc vs. Kubota Corporation
IngersollRand Plc vs. Kubota Corporation


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium